A new grant from the Spanish government has been awarded to PIs Dr. Ricardo Pérez-Tomás and Dr. Vanessa Soto-Cerrato for the therapeutic preclinical evaluation of new survivin inhibitors for cancer treatment.
A new grant from the Spanish government has been awarded to PIs Dr. Ricardo Pérez-Tomás and Dr. Vanessa Soto-Cerrato for the therapeutic preclinical evaluation of new survivin inhibitors for cancer treatment.